Viral vectors encoding GLP-2 receptor agonist fusions and their use in treating short bowel syndrome

JP2025509193A5Pending Publication Date: 2026-03-11THE TRUSTEES OF THE UNIV OF PENNSYLVANIA
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-03-03
Publication Date
2026-03-11

Smart Images

  • Figure 00000047_0000
    Figure 00000047_0000
  • Figure 00000047_0001
    Figure 00000047_0001
  • Figure 00000047_0002
    Figure 00000047_0002
Patent Text Reader

Abstract

Compositions and methods are provided for treating short bowel syndrome in a subject. A viral vector is provided that includes a nucleic acid molecule that includes a sequence encoding a GLP-2 receptor agonist fusion protein and a regulatory sequence that directs its expression.
Need to check novelty before this filing date? Find Prior Art